Augmedix: Secular AI Tailwinds, But Still Unattractive Risk-Reward

ljubaphoto/E+ via Getty Images Augmedix (NASDAQ:AUGX) is a company developing AI-driven medical documentation platform for hospital and physicians Share performance has been underwhelming since going public in 2021 at the price of $5. All-time return stands at -15% today, with the stock most recently trading at $4.3. The weak all-time return is partially driven by the lackluster performance YTD. Having reached $5.8 at the start of the year in January, share price has continued to trend down since. AUGX  ...